Literature DB >> 25556037

The management of chronic breathlessness in patients with advanced and terminal illness.

Magnus P Ekström1, Amy P Abernethy2, David C Currow3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25556037     DOI： 10.1136/bmj.g7617

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  19 in total

1.  Opioids in chronic obstructive pulmonary disease: the whole picture using all available evidence.

Authors:  David C Currow; Magnus Ekström; Miriam J Johnson
Journal:  Br J Clin Pharmacol       Date:  2016-01-04       Impact factor: 4.335

Review 2.  Updates in palliative care - recent advancements in the pharmacological management of symptoms.

Authors:  Angela Star; Jason W Boland
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

3.  Burden of Restricted Activity and Associated Symptoms and Problems in Late Life and at the End of Life.

Authors:  Thomas M Gill; Heather G Allore; Evelyne A Gahbauer; Terrence E Murphy
Journal:  J Am Geriatr Soc       Date:  2018-10-02       Impact factor: 5.562

4.  A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease.

Authors:  Janet Hardy; Clare Randall; Eve Pinkerton; Christopher Flatley; Kristen Gibbons; Simon Allan
Journal:  Support Care Cancer       Date:  2016-02-18       Impact factor: 3.603

Review 5.  Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.

Authors:  Steffen T Simon; Irene J Higginson; Sara Booth; Richard Harding; Vera Weingärtner; Claudia Bausewein
Journal:  Cochrane Database Syst Rev       Date:  2016-10-20

6.  Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.

Authors:  Zainab Ahmadi; Eva Bernelid; David C Currow; Magnus Ekström
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-21

7.  Swedish translation and linguistic validation of the multidimensional dyspnoea profile.

Authors:  Magnus Ekström; Josefin Sundh
Journal:  Eur Clin Respir J       Date:  2016-11-08

8.  A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.

Authors:  David Currow; Gareth John Watts; Miriam Johnson; Christine F McDonald; John O Miners; Andrew A Somogyi; Linda Denehy; Nicola McCaffrey; Danny J Eckert; Philip McCloud; Sandra Louw; Lawrence Lam; Aine Greene; Belinda Fazekas; Katherine C Clark; Kwun Fong; Meera R Agar; Rohit Joshi; Sharon Kilbreath; Diana Ferreira; Magnus Ekström
Journal:  BMJ Open       Date:  2017-07-17       Impact factor: 2.692

9.  Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study.

Authors:  M Ekström; M J Johnson; L Schiöler; S Kaasa; M J Hjermstad; D C Currow
Journal:  Support Care Cancer       Date:  2016-04-09       Impact factor: 3.603

10.  Trends in Restricting Symptoms at the End of Life from 1998 to 2019: A Cohort Study of Older Persons.

Authors:  Thomas M Gill; Evelyne A Gahbauer; Linda Leo-Summers; Terrence E Murphy
Journal:  J Am Geriatr Soc       Date:  2020-11-03       Impact factor: 5.562
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.